Protect Pharmaceutical Corporation
PRTT - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$7.47M
Close$
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $7.47 Million |
|---|---|
| Enterprise Value | - |
| Earnings per Share | $-5.79 |
| Beta | 2.09 |
| Outstanding Shares | 57,451,378 |
Return
| Return on Equity | NaN% |
|---|---|
| Return on Assets | NaN% |
| Return on Invested Capital | NaN% |
Valuation & Multiples
| P/E Ratio | -347.38 |
|---|---|
| PEG | 346.34 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | - |
| Enterprise Value to Net Income | - |
| Total Debt to Enterprise | - |
| Debt to Equity | - |
Revenue Sources
No data
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About Protect Pharmaceutical Corporation
600 employees
CEO: Boris Stepanov
Protect Pharmaceutical Corporation primarily focuses on crop farming and agricultural businesses. It acquires the Can Noguera property located in Selva Girona region in Spain. Its property consists of 60 hectares of arable land, 390 hect...